ASSET | DATE | % RETURN |
---|---|---|
Inventrust Properties (IVT) | 9/1/2016 - 10/15/2016 | 934,108.33% |
OLB (OLB) | 9/1/2016 - 10/15/2016 | 300% |
Nova Lifestyle I (NVFY) | 9/1/2016 - 10/15/2016 | 274.75% |
Clearside Biomedical (CLSD) | 9/1/2016 - 10/15/2016 | 181.96% |
Alpha Metallurgical Resources (AMR) | 9/1/2016 - 10/15/2016 | 160% |
Renovaro Biosciences (RENB) | 9/1/2016 - 10/15/2016 | 140.96% |
Cronos (CRON) | 9/1/2016 - 10/15/2016 | 136.9% |
Aurora Cannabis (ACB) | 9/1/2016 - 10/15/2016 | 135.85% |
Matinas BioPharma (MTNB) | 9/1/2016 - 10/15/2016 | 134.18% |
Datasea (DTSS) | 9/1/2016 - 10/15/2016 | 122.22% |
CEA Industries (CEAD) | 9/1/2016 - 10/15/2016 | 120.91% |
Corbus Pharmaceuticals (CRBP) | 9/1/2016 - 10/15/2016 | 116.22% |
Collegium Pharmaceutical (COLL) | 9/1/2016 - 10/15/2016 | 112.08% |
Aurinia Pharmaceuticals (AUPH) | 9/1/2016 - 10/15/2016 | 110.1% |
InMed Pharmaceuticals (INM) | 9/1/2016 - 10/15/2016 | 108.02% |
Sarepta Therapeutics (SRPT) | 9/1/2016 - 10/15/2016 | 101.93% |
Merus (MRUS) | 9/1/2016 - 10/15/2016 | 92.42% |
Assembly Biosciences (ASMB) | 9/1/2016 - 10/15/2016 | 89.43% |
Bone Biologics (BBLG) | 9/1/2016 - 10/15/2016 | 80% |
Protagonist Therapeutics (PTGX) | 9/1/2016 - 10/15/2016 | 78.68% |
TSS, Inc Common Stock (TSSI) | 9/1/2016 - 10/15/2016 | 76.92% |
XWELL (XWEL) | 9/1/2016 - 10/15/2016 | 72.33% |
Usio (USIO) | 9/1/2016 - 10/15/2016 | 72.11% |
OrganiGram (OGI) | 9/1/2016 - 10/15/2016 | 69.62% |
Hepion Pharmaceuticals (HEPA) | 9/1/2016 - 10/15/2016 | 67.54% |